ClinicalTrials.Veeva

Menu

ReSure Sealant Post Approval Study (Clinical PAS)

Ocular Therapeutix logo

Ocular Therapeutix

Status

Completed

Conditions

Adverse Events

Treatments

Device: ReSure Sealant

Study type

Observational

Funder types

Industry

Identifiers

NCT02310815
OTX-13-003

Details and patient eligibility

About

This is a prospective multicenter observational post-approval registry study that will collect post-approval data relative to the incidence of pre-specified Adverse Ocular Events for cataract surgery patients treated with the FDA-approved ReSure Sealant when used by a broad group of physicians under commercial use conditions.

Enrollment

626 patients

Sex

All

Ages

22+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subject has a cataract and is expected to undergo clear corneal cataract surgery with intraocular lens placement

Exclusion criteria

  • ReSure Sealant is not applied to the operative eye

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems